Mr. Speaker, without taking all the time remaining to me, I would like to get to my conclusion.
In my speech on this important bill, I mentioned all the contributions made by the hon. member for Windsor West to the former Bill C-9. It is a very important act, which, as we know, is affected by Bill C-29.
Bill C-29, an act to amend the Patent Act does speak to pharmaceutical patents, but in addition—and that is unfortunate—it amends former the Bill C-9, to which the hon. member for Windsor West contributed so much. As we know, Bill C-9 deals with the entire question of AIDS, which is rampant in Africa and causing a crisis all across it.
What is so unfortunate about Bill C-29? It modifies former Bill C-9 and the government is, in a way, eliminating the fact that representatives of the Senate can sit on the advisory committee that will, in fact, be making decisions about which pharmaceuticals will be on the list of drugs available for export.
Because of that, we are somewhat hesitant to give our support to Bill C-29. It is unfortunate because the primary goal of the bill as it now appears, was not to make these changes to the former Bill C-9.
At the same time, it is very important to emphasize that we consider former Bill C-9 extremely useful in resolving or beginning to resolve the crisis in Africa. Since the regulations will not come into force for several years—and even though Africa cannot wait—we must wait in order to be able to help Africans to the fullest.
For this reason we will support Bill C-29 only bring about the implementation of the regulations of former Bill C-9 as quickly as possible, so that we will finally be able to help the people of Africa, who need it so much.